News
TEVA
35.32
+2.32%
0.80
Teva Shareholders Back Board, Executive Pay and Auditor
TipRanks · 1d ago
Teva shareholders approved executive pay in advisory vote at annual meeting
PUBT · 1d ago
Consumers could pay less for drugs with Mark Cuban pharmacy than own insurance
Seeking Alpha · 1d ago
Teva Pharmaceuticals adopts Veeva Vault CRM globally, Veeva says
PUBT · 1d ago
J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?
NASDAQ · 1d ago
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Thermo Fisher (TMO) and Eli Lilly & Co (LLY)
TipRanks · 2d ago
Teva commits to Veeva Vault CRM
TipRanks · 2d ago
Teva commits to adopt Veeva Vault CRM globally
PUBT · 2d ago
Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
Benzinga · 4d ago
Weekly Report: what happened at TEVA last week (0518-0522)?
Weekly Report · 5d ago
TEVA's Growth Story Is No Longer Just Generic, It's Getting Branded
Seeking Alpha · 5d ago
A Look At Teva (NYSE:TEVA) Valuation After EMA Accepts Filing For Monthly Schizophrenia Injection
Simply Wall St · 5d ago
Will Teva’s New TD Data on Young Adults Shift Its Neuroscience-Focused Investment Narrative (TEVA)?
Simply Wall St · 6d ago
Teva: European Medicines Agency Accepts Marketing Authorization Application For TEV-'749
NASDAQ · 05/22 05:32
EMA accepts Teva filing for Medincell long-acting olanzapine schizophrenia injection
PUBT · 05/21 17:24
Teva announces EMA acceptance of MAA for olanzapine long-acting injectable
TipRanks · 05/21 16:35
Teva Pharmaceutical Industries Subsidiary And Medincell Says European Medicines Agency Has Accepted The Marketing Authorization Application For Olanzapine Long-Acting Injectable (TEV-'749) For The Treatment Of Schizophrenia In Adults
Benzinga · 05/21 16:33
EMA accepts Teva application for monthly olanzapine injectable schizophrenia treatment
PUBT · 05/21 16:30
THE EUROPEAN MEDICINES AGENCY ACCEPTS TEVA’S MARKETING AUTHORIZATION APPLICATION FOR OLANZAPINE LONG-ACTING INJECTABLE (TEV-‘749) FOR THE TREATMENT OF SCHIZOPHRENIA IN ADULTS
Reuters · 05/21 16:30
Hims & Hers launches generics for Novo’s semaglutide in Canada
Seeking Alpha · 05/21 13:29
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.